Pulmonary pharmacology and therapeutics

Pulmonary pharmacology and therapeutics

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
David M.G. Halpin, Sally Worsley, Afisi S. Ismaila, Kai-Michael Beeh, Dawn Midwinter, Janwillem W.H. Kocks, Elaine Irving, Jose M. Marin, Neil Martin, Maggie Tabberer, Neil G. Snowise, Chris Compton

ERJ Open Research Apr 2021, 7 (2) 00950-2020; DOI: 10.1183/23120541.00950-2020
Anti-HSP47 siRNA lipid nanoparticle ND-L02-s0201 reverses interstitial pulmonary fibrosis in preclinical rat models
Yun Liu, Jian Liu, Alistair Quimbo, Fengcheng Xia, Jiping Yao, Jean-Pierre Clamme, Sonya Zabludoff, Jun Zhang, Wenbin Ying

ERJ Open Research Apr 2021, 7 (2) 00733-2020; DOI: 10.1183/23120541.00733-2020
Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial
Jutta Beier, Henrik Watz, Zuzana Diamant, Jens M. Hohlfeld, Dave Singh, Pascale Pinot, Ieuan Jones, Hanns-Christian Tillmann

ERJ Open Research Apr 2021, 7 (2) 00425-2020; DOI: 10.1183/23120541.00425-2020
Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
Anne H. Neerincx, Katrine Whiteson, Joann L. Phan, Paul Brinkman, Mahmoud I. Abdel-Aziz, Els J.M. Weersink, Josje Altenburg, Christof J. Majoor, Anke H. Maitland-van der Zee, Lieuwe D.J. Bos

ERJ Open Research Apr 2021, 7 (2) 00731-2020; DOI: 10.1183/23120541.00731-2020
High-dose glucocorticoid treatment of near-fatal bocavirus lung infection results in rapid recovery
Matthias Obenaus, Oliver Schildgen, Dirk Schürmann, Ann-Christin von Brünneck, Martin Janz, Ulrich Keller, Bernhard Gebauer, Johannes Schilling, Stefan Schwartz, Benedikt Weissbrich, Thomas Schneider, Jörg Hofmann, Stephan Mathas

ERJ Open Research Apr 2021, 7 (2) 00060-2021; DOI: 10.1183/23120541.00060-2021
Effect of fexofenadine hydrochloride on allergic rhinitis aggravated by air pollutants
Anne K. Ellis, Margarita Murrieta-Aguttes, Sandy Furey, Pascaline Picard, Christopher Carlsten

ERJ Open Research Apr 2021, 7 (2) 00806-2020; DOI: 10.1183/23120541.00806-2020
Time on therapy and concomitant medication use of mepolizumab in Canada: a retrospective cohort study
Jason K. Lee, Alain Gendron, Michelle Knutson, Niroshan Sriskandarajah, Lawrence Mbuagbaw, Stephen G. Noorduyn

ERJ Open Research Jan 2021, 7 (1) 00778-2020; DOI: 10.1183/23120541.00778-2020
Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia
Gerard Moreno, Alejandro Rodríguez, Jordi Sole-Violán, Ignacio Martín-Loeches, Emili Díaz, María Bodí, Luis F. Reyes, Josep Gómez, Juan Guardiola, Sandra Trefler, Loreto Vidaur, Elisabet Papiol, Lorenzo Socias, Carolina García-Vidal, Eudald Correig, Judith Marín-Corral, Marcos I. Restrepo, Jonathan S. Nguyen-Van-Tam, Antoni Torres

ERJ Open Research Jan 2021, 7 (1) 00888-2020; DOI: 10.1183/23120541.00888-2020
The safety of cardioselective β₁-blockers in asthma: literature review and search of global pharmacovigilance safety reports
Miriam Bennett, Catherina L. Chang, Michael Tatley, Ruth Savage, Robert J. Hancox

ERJ Open Research Jan 2021, 7 (1) 00801-2020; DOI: 10.1183/23120541.00801-2020
Treatment with antifibrotic agents in idiopathic pleuroparenchymal fibroelastosis with usual interstitial pneumonia
Keishi Sugino, Hirotaka Ono, Hiroshige Shimizu, Takeyuki Kurosawa, Keiko Matsumoto, Masahiro Ando, Kiyoshi Mori, Eiyasu Tsuboi, Sakae Homma, Kazuma Kishi

ERJ Open Research Jan 2021, 7 (1) 00196-2020; DOI: 10.1183/23120541.00196-2020

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages

Contact us